🔗 Permalink

Assignee profile:

ZYNERBA PHARMACEUTICALS, INC.

City:

Devon, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2025-07-03

Patent Grants:

Last grant date:

2025-02-18

Top Inventors for applications by ZYNERBA PHARMACEUTICALS, INC.

These are the the leading inventors for applications assigned to ZYNERBA PHARMACEUTICALS, INC.:

Donna Gutterman 27 Raleigh, NC United States
Terri Sebree 26 Gladwyne, PA United States
John Messenheimer 14 Moncure, NC United States
Marcel Bonn-Miller 12 Lexington, NC United States

Miroslaw Jerzy GOLINSKI 11 Lexington, KY United States
Dana Carmel HAMMELL 11 Georgetown, KY United States
Audra Lynn STINCHCOMB 10 Ruxton, MD United States
Jeffrey Lynn HOWARD 9 Lexington, KY United States

Nancy Tich 5 Saint Paul, MN United States
Joseph Palumbo 5 Saint Davids, PA United States
Ted Smith 4 Tubac, AZ United States
James Griesser 4 Havertown, PA United States

Nancy Tich 4 Chester, NJ United States
Daniel Clauw 3 Ann Arbor, MI United States
Thomas W. Dobbins 2 Blue Bell, PA United States
Stephen V. O'Quinn 2 Wake Forest, NC United States

Audra Lynn STINCHCOMB 1 Lexington, KY United States
Carol O'Neill 1 Scottsdale, AZ United States
Stan Lee BANKS 1 Frankfort, KY United States
Jeffery Lynn HOWARD 1 Richmond, KY United States

Theodore Smith 1 Tubac, AZ United States
Jeffery Lynn Howard 1 Lexington, KY United States

Recent patent applications by ZYNERBA PHARMACEUTICALS, INC.

ZYNERBA PHARMACEUTICALS, INC. based in Devon, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-07-03

US20250213465A1

Human necessities

SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

#2 | 2025-01-30

US20250034104A1

Chemistry; metallurgy

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#3 | 2024-10-17

US20240342198A1

Human necessities

TREATMENT OF IRRITABILITY IN SUBJECTS WITH AUTISM SPECTRUM DISORDERS WITH MODERATE TO SEVERE ANXIETY AND/OR SOCIAL AVOIDANCE

#4 | 2024-09-19

US20240307418A1

Human necessities

TREATMENT OF SLEEP APNEA WITH CBD

#5 | 2024-07-04

US20240217942A1

Chemistry; metallurgy

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#6 | 2024-06-13

US20240189255A1

Human necessities

METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL

#7 | 2024-05-09

US20240148669A1

Human necessities

METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL

#8 | 2024-04-18

US20240122873A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

#9 | 2024-03-14

US20240083866A1

Chemistry; metallurgy

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#10 | 2024-01-11

US20240009210A1

Human necessities

Cannabidiol for the Treatment of Refractory Seizures

#11 | 2023-12-28 ✅ Patent 12,226,373 granted on 2025-02-18

US20230414533A1

Human necessities

Treatment of fragile X syndrome with cannabidiol

#12 | 2023-11-16 ✅ Patent 12,213,951 granted on 2025-02-04

US20230364028A1

Human necessities

Treatment of autism with cannabidiol

#13 | 2023-02-23

US20230059709A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

#14 | 2023-01-26 ✅ Patent 12,186,282 granted on 2025-01-07

US20230024756A1

Human necessities

Treatment of 22Q11.2 deletion syndrome with cannabidiol

#15 | 2023-01-05

US20230000793A1

Human necessities

TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOL

#16 | 2023-01-05

US20230000792A1

Human necessities

TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOL

#17 | 2023-01-05 ✅ Patent 11,779,549 granted on 2023-10-10

US20230000790A1

Human necessities

Treatment of Fragile X Syndrome with cannabidiol

#18 | 2022-07-14

US20220218625A1

Human necessities

TREATMENT OF BEHAVIORAL IMPAIRMENT IN DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY

#19 | 2022-06-23

US20220194916A1

Chemistry; metallurgy

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#20 | 2022-03-31

US20220096396A1

Human necessities

TREATMENT OF AUTISM WITH CANNABIDIOL

#21 | 2021-12-30

US20210401769A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

#22 | 2021-12-02

US20210369643A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME AND AUTISM SPECTRUM DISORDER WITH CANNABIDIOL

#23 | 2021-03-18

US20210077421A1

Human necessities

TREATMENT OF SYNGAP1 ENCEPHALOPATHY

#24 | 2021-02-18

US20210047284A1

Chemistry; metallurgy

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#25 | 2021-02-04

US20210030665A1

Human necessities

SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

#26 | 2020-11-19 ✅ Patent 11,458,110 granted on 2022-10-04

US20200360299A1

Human necessities

Treatment of Fragile X Syndrome with cannabidiol

#27 | 2020-08-06

US20200247774A1

Chemistry; metallurgy

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#28 | 2020-07-09

US20200214995A1

Human necessities

TREATMENT OF AUTISM WITH CANNABIDIOL

#29 | 2020-06-18 ✅ Patent 11,458,109 granted on 2022-10-04

US20200188324A1

Human necessities

Treatment of 22Q11.2 deletion syndrome with cannabidiol

#30 | 2020-06-04

US20200170963A1

Human necessities

METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL

#31 | 2020-01-30 ✅ Patent 10,758,497 granted on 2020-09-01

US20200030255A1

Human necessities

Treatment of fragile x syndrome with cannabidiol

#32 | 2020-01-23

US20200024248A1

Chemistry; metallurgy

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#33 | 2019-08-29 ✅ Patent 10,568,848 granted on 2020-02-25

US20190262280A1

Human necessities

Treatment of autism with cannabidiol

#34 | 2019-08-01

US20190233387A1

Chemistry; metallurgy

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#35 | 2019-06-06 ✅ Patent 10,471,022 granted on 2019-11-12

US20190167605A1

Human necessities

Treatment of fragile X syndrome with cannabidiol

#36 | 2019-04-25 ✅ Patent 10,314,792 granted on 2019-06-11

US20190117588A1

Human necessities

Treatment of autism with cannabidiol

#37 | 2019-03-21

US20190083388A1

Human necessities

SYNTHENTIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

#38 | 2019-02-26 ✅ Patent 10,213,390 granted on 2019-02-26

US16144632

Human necessities

Treatment of fragile X syndrome with cannabidiol

#39 | 2017-03-30 ✅ Patent 9,957,246 granted on 2018-05-01

US20170088533A1

Chemistry; metallurgy

Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same

#40 | 2015-08-06 ✅ Patent 9,695,143 granted on 2017-07-04

US20150218121A1

Chemistry; metallurgy

Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same

#41 | 2015-07-16 ✅ Patent 9,533,942 granted on 2017-01-03

US20150197484A1

Chemistry; metallurgy

Use of cannabidiol prodrugs in topical and transdermal administration with microneedles

Also check out ZYNERBA PHARMACEUTICALS, INC.'s (Devon, United States) applicant profile with 18 patent applications submitted.

AssigneeID:

146495 ⎘